<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:PODD (USA) Also Trade In: Germany

Insulet Corp $ 155.61 0 (0%)

Volume:
501,916
Avg Vol (1m):
924,317
Market Cap $:
9.56 Bil
Enterprise Value $:
9.86 Bil
P/E (TTM):
555.79
P/B:
38.32
Warning! GuruFocus has detected 2 Severe warning signs with PODD. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

PODD News and Headlines - Insuletrp

GuruFocus Articles Total 25
  • 1
  • 2

The companies are well positioned to continue to benefit from the demand for on-body drug delivery systems

With rapid growth projected for the market for wearable drug delivery devices, investors would be wise to consider some of the key players in the business.

Two standouts are Boston-area-based Insulet (PODD) and West Pharmaceutical Services (WST), which is headquartered in Exton, Pennsylvania. These companies don’t make the drugs. They develop the devices patients wear that deliver the medications.

Both firms have rewarded shareholders handsomely. Insulet, which is worth more than $6 billion, trades at more than $103. That’s up more than 150% during the past five years. West has been even more generous to its faithful. Shares

53 Views    Barry Cohen    2019-05-15 15:28

NEW YORK, April 09, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Under Armour, Inc. (:UA), USA Compression Partners, LP (:USAC), JELD-WEN Holding, Inc. (:JELD), Insulet Corporation (PODD), Fiesta Restaurant Group, Inc. (FRGI), and Enstar Group Limited (ESGR), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at

0 Views    Marketwired    2019-04-09 16:01
Small-cap guru’s largest new holding is Tandem Diabetes Care

Daruma Capital Management leader Mariko Gordon (Trades, Portfolio) disclosed she established seven new positions when she released her fourth-quarter 2018 portfolio earlier this week.

Managing a concentrated portfolio of small and mid-cap stocks, the New York-based firm says on its website that it believes the best time to invest in a company is not just when it offers good value, but also when clear catalysts can be identified, which will send the price higher.

Based on these criteria, Gordon’s top five new buys for the quarter were Tandem Diabetes Care Inc. (TNDM), Macom Technology Solutions Holdings

221 Views    Sydnee Gatewood    2019-02-15 23:16

NEW YORK, Feb. 07, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of IHS Markit Ltd. (INFO), KB Home (:KBH), Insulet Corporation (PODD), Booking Holdings Inc. (BKNG), Diebold Nixdorf, Incorporated (:DBD), and Seritage Growth Properties (:SRG), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

0 Views    Marketwired    2019-02-07 17:04
A unique delivery method should support this company in the face of competition

The prevalence of diabetes is growing rapidly, both in the developed and developing worlds. A 2017 CDC report found that 30.3 million Americans (9.4% of the total population) suffer from diabetes. Worldwide, the prevalence of diabetes in adults over the age of 18 has grown from 4.7% (108 million patients) in 1980 to 8.5% in 2014 (422 million patients). The total diabetic population is projected to grow to around 693 million by 2045. Clearly, this is a massive and expanding market, and for investors looking for exposure to it, Insulet (PODD) offers an interesting opportunity.

Insulet

87 Views    John Engle    2018-12-01 22:48
Billionaire guru discloses stake in respiratory medical device manufacturer

Point72 Asset Management leader Steven Cohen (Trades, Portfolio) revealed a 5.28% stake in Inogen Inc. (INGN) on Nov. 28.

To generate superior risk-adjusted returns, the billionaire investor’s Connecticut-based hedge fund utilizes long, short, macro and systematic strategies.

According to GuruFocus real-time picks, a premium feature, Cohen picked up 1.14 million shares of the Goleta, California-based company for an average price of $141.24 per share, allocating 0.66% of the equity portfolio to the position. He previously sold out of the stock in the third quarter of 2017.

The medical device manufacturer, which makes portable oxygen concentrators for

184 Views    Sydnee Gatewood    2018-11-30 17:29

NEW YORK, Nov. 29, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Insulet Corporation (PODD), Yum China Holdings Inc. (:YUMC), Triton International Limited (:TRTN), Tetra Technologies, Inc. (:TTI), Motorola Solutions, Inc. (:MSI), and Spotify Technology SA (:SPOT), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the

0 Views    Marketwired    2018-11-29 17:03
The fund’s largest new position is Elanco Animal Health

The Vanguard Health Care Fund (Trades, Portfolio) released its third-quarter portfolio last week, listing four new positions.

Managed by Jean Hynes, the fund invests in a number of diverse health care-related stocks from around the world in order to achieve long-term capital appreciation. She picks stocks of companies that have high-quality balance sheets, strong management teams and the potential for new products that will contribute to generate above-average revenue and earnings growth.

Based on these criteria, the fund established positions in Elanco Animal Health Inc. (ELAN), Insulet Corp. (PODD), Qiagen NV (QGEN) and NMC Health PLC (LSE:NMC)

114 Views    Sydnee Gatewood    2018-11-07 17:40

TUV Rheinland OpenSky helps Insulet Corporation’s Omnipod® DASH™ Insulin Management System to be the first FDA-cleared insulin pump to achieve certification under the Diabetes Technology Society’s cybersecurity assurance standard and program, known as DTSec

TUV Rheinland OpenSky, DTSec Accredited Lab and the world's premier cybersecurity testing services provider achieve another first in cybersecurity certification for internet-enabled medical devices

COLOGNE, Germany and LITTLETON, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Diabetes Technology Society announced that the first FDA cleared insulin pump has received certification

0 Views    Marketwired    2018-11-06 17:02

NEW YORK, May 31, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Insulet Corporation (PODD), Everi Holdings Inc. (:EVRI), Ciner Resources LP (:CINR), Aluminum Corporation of China Limited (:ACH), Okta, Inc. (OKTA), and MYOS RENS Technology Inc. (MYOS), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links

0 Views    Marketwired    2018-05-31 12:02
Insiders purchase shares of Sohu.com, Insulet, PJT, SiteOne and CoreSite

According to GuruFocus’ Insider Data, these are the largest CEO buys during the past week. The overall trend of purchases is illustrated in the chart below:

Sohu.com CEO bought 48,000 shares

Sohu.com Inc. (SOHU) CEO and 10% owner Charles Zhang bought 48,000 shares for $34.27 per share in the past week. The stock price has increased by 7.24% since.

Zhang bought 16,000 shares for $33.6 per share on Dec. 2, 16,000 shares for $33.6 per share on Dec. 6 and 16,000 shares for $35.6 per share on Dec. 8.

Sohu.com is a Chinese online media,

96 Views    Joy Hu    2016-12-12 15:14
CEO purchases 40,000 shares

Insulet Corp. (PODD) CEO and Chairman Patrick Sullivan (Insider Trades) acquired 40,000 shares of the company on Dec. 2. The price was $33.89 per share for a total transaction of $1,355,600.

Insulet is a medical device company focused on diabetes management. The company seeks to help patients with insulin-dependent diabetes with its Omnipod Insulin Management System. Insulet has a market cap of $2.02 billion.

The volume of insider buys increased while the number of insider sells decreased each year since 2013. There were 20 insider sells totaling 508,766 shares in 2013, and seven insider sells totaling 39,997 shares

138 Views    Jennifer Chiou    2016-12-06 16:32

Mariko Gordon (Trades, Portfolio), CFA, is the founder of Daruma Capital Management which is a 100% employee-owned company. She started the firm in 1995 with zero assets but with a clear goal: to build an investment firm where the business of money management would never interfere with her calling as a portfolio manager. Her role at Daruma is to ensure that they never become complacent, and that they always strive to enhance their investment process. She runs a concentrated portfolio of no less than 25 stocks. The firm now has more than $2

3841 Views    Tiziano Frateschi    2015-06-12 16:12

NuVasive Inc (NUVA): Chairman & CEO Gregory T Lucier Bought 34,000 Shares

Chairman & CEO of NuVasive Inc (NUVA) Gregory T Lucier bought 34,000 shares on May 28 at an average price of $49.85. NuVasive Inc was incorporated in Delaware on July 21, 1997, and began commercializing its products in 2001. Nuvasive Inc has a market cap of $2.41 billion; its shares were traded at around $49.85 with a P/E ratio of 77.70 and P/S ratio of 3.10.

NuVasive reported first quarter 2015 total revenue of $192.4 million, an 8.4% increase compared to $177.5

6560 Views    hyperman299    2015-06-02 14:50
President and CEO of Insulet Corp. (PODD) Duane Desisto sells 24,400 shares of PODD on 02/16/2011 at an average price of $18.04 a share. Insulet Corp. has a market cap of $794.8 million; its shares were traded at around $18.41 with and P/S ratio of 12.1. Hedge Fund Gurus that owns PODD: [url=http://www.gurufocus.com/StockBuy.php?GuruName=Manning+%26+Napier+Advisors%2C+Inc]Manning & Napier Advisors, Inc[/url], [url=http://www.gurufocus.com/StockBuy.php?GuruName=Steven+Cohen]Steven Cohen[/url] of SAC Capital Advisors. Mutual Fund and Other Gurus that owns PODD: [url=http://www.gurufocus.com/StockBuy.php?GuruName=Pioneer+Investments]Pioneer Investments[/url].

CEO Recent Trades:

  • [color=red][b]Sell:[/b][/color] President and CEO Duane Desisto sold 27,000 shares of PODD stock on 02/14/2011 at the average price of 18.01. Duane Desisto owns
478 Views    insider    2011-02-18 23:21
President and CEO of Insulet Corp. (PODD) Duane Desisto sells 27,000 shares of PODD on 02/14/2011 at an average price of $18.01 a share. Insulet Corp. has a market cap of $770.6 million; its shares were traded at around $17.85 with and P/S ratio of 11.7. Hedge Fund Gurus that owns PODD: [url=http://www.gurufocus.com/StockBuy.php?GuruName=Manning+%26+Napier+Advisors%2C+Inc]Manning & Napier Advisors, Inc[/url], [url=http://www.gurufocus.com/StockBuy.php?GuruName=Steven+Cohen]Steven Cohen[/url] of SAC Capital Advisors. Mutual Fund and Other Gurus that owns PODD: [url=http://www.gurufocus.com/StockBuy.php?GuruName=Pioneer+Investments]Pioneer Investments[/url].

Directors and Officers Recent Trades:

  • [color=red][b]Sell:[/b][/color] Vice President, International Carsten Boess sold 5,056 shares of PODD stock on 02/07/2011 at the average price of 17.5. Carsten
379 Views    insider    2011-02-16 01:18

Insulet Corp. (PODD) filed Quarterly Report for the period ended 2010-06-30. Insulet Corp. has a market cap of $569.55 million; its shares were traded at around $15.01 with and P/S ratio of 8.63.

PODD is in the portfolios of [url=http://www.gurufocus.com/StockBuy.php?GuruName=RS+Investment+Management]RS Investment Management[/url], [url=http://www.gurufocus.com/StockBuy.php?GuruName=Manning+%26+Napier+Advisors%2C+Inc]Manning & Napier Advisors, Inc[/url], [url=http://www.gurufocus.com/StockBuy.php?GuruName=Pioneer+Investments]Pioneer Investments[/url], [url=http://www.gurufocus.com/StockBuy.php?GuruName=Steven+Cohen]Steven Cohen[/url] of SAC Capital Advisors.

Highlight of Business Operations:

Since our inception in 2000, we have incurred losses every quarter. In the three and six months ended June 30, 2010, we incurred net losses of $13.7 million and $28.2 million, respectively. As of June 30, 2010, we had an accumulated

343 Views    gurufocus    2010-08-09 21:43

Insulet Corp. (PODD) filed Quarterly Report for the period ended 2010-06-30. Insulet Corp. has a market cap of $569.55 million; its shares were traded at around $15.01 with and P/S ratio of 8.63.

PODD is in the portfolios of [url=http://www.gurufocus.com/StockBuy.php?GuruName=RS+Investment+Management]RS Investment Management[/url], [url=http://www.gurufocus.com/StockBuy.php?GuruName=Manning+%26+Napier+Advisors%2C+Inc]Manning & Napier Advisors, Inc[/url], [url=http://www.gurufocus.com/StockBuy.php?GuruName=Pioneer+Investments]Pioneer Investments[/url], [url=http://www.gurufocus.com/StockBuy.php?GuruName=Steven+Cohen]Steven Cohen[/url] of SAC Capital Advisors.

Highlight of Business Operations:

Since our inception in 2000, we have incurred losses every quarter. In the three and six months ended June 30, 2010, we incurred net losses of $13.7 million and $28.2 million, respectively. As of June 30, 2010, we had an accumulated

508 Views    gurufocus    2010-08-09 21:43

Insulet Corp. (PODD) filed Quarterly Report for the period ended 2010-03-31. Insulet Corp. has a market cap of $500.4 million; its shares were traded at around $13.21 with and P/S ratio of 7.6.

PODD is in the portfolios of [url=http://www.gurufocus.com/StockBuy.php?GuruName=RS+Investment+Management]RS Investment Management[/url], [url=http://www.gurufocus.com/StockBuy.php?GuruName=Steven+Cohen]Steven Cohen[/url] of SAC Capital Advisors.

Highlight of Business Operations:

Since our inception in 2000, we have incurred losses every quarter. In the three months ended March 31, 2010, we incurred net losses of $13.9 million. As of March 31, 2010, we had an accumulated deficit of $343.7 million. We have financed our operations through the private placement

632 Views    gurufocus    2010-05-07 20:19
COO of Insulet Corp. (PODD) Luis Malave sells 6,000 shares of PODD on 12/22/2009 at an average price of $14.14 a share. INSULET CORPORATION is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use components with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. Insulet Corp. has a market cap of $513.2 million; its shares were
1073 Views    insider    2009-12-23 22:16

Headlines Total 116
  • 1
  • 2

2019-10-02 $ 157.31 (-3.39%)
11:50pm
2019-09-25 $ 165.56 (0.63%)
3:00pm
2019-09-24 $ 164.52 (3.8%)
8:20am
2019-09-14
8:54am
2019-09-04 $ 157.12 (-6.45%)
8:30am
8:30am
8:24am
7:40am
2019-08-14 $ 146.39 (-4.18%)
8:35am
2019-08-13 $ 152.77 (1.14%)
2:31pm
6:01am
2019-08-07 $ 142.34 (-0.55%)
10:36am
8:15am
2019-08-06 $ 143.13 (21.37%)
3:09pm
10:54am
2019-08-05 $ 117.93 (-2.45%)
10:52pm
4:25pm
2019-07-29 $ 125.11 (0.9%)
9:34am
2019-07-15 $ 120.7 (0.37%)
10:00am
8:15am
2019-06-13 $ 116.89 (0.9%)
6:59am
2019-06-04 $ 111.79 (2.26%)
7:18am
2019-06-01
8:31am
2019-05-15 $ 104.09 (0.72%)
10:28am
2019-05-13 $ 101.4 (-1.73%)
3:00am
2019-05-10 $ 103.18 (-1.62%)
12:02pm
2019-05-04
3:00pm
2019-05-03 $ 96.67 (12.3%)
12:11pm
9:14am
7:02am
2019-05-02 $ 86.08 (1.47%)
9:10pm
4:45pm
2019-04-29 $ 86.12 (1.16%)
9:10am
8:01am
2019-04-25 $ 83.2 (-0.14%)
9:33am
2019-04-13
7:30pm
2019-03-27 $ 93.39 (-3.48%)
8:30am
2019-03-16
6:00am
2019-03-03
11:32am
2019-02-27 $ 93.52 (1.53%)
5:55am
2019-02-26 $ 92.11 (2.44%)
12:36am
2019-02-18 $ 88.46 (%)
9:30am
2019-01-10 $ 74.22 (-0.88%)
6:17am
2018-12-10 $ 82.49 (2.15%)
8:01am
2018-12-01
4:48pm
Insulet: Sugar or Spice? - GuruFocus.com
8:31am
2018-11-29 $ 85.05 (0.97%)
11:03am
2018-11-23 $ 77.32 (-0.99%)
9:11am
2018-11-22 $ 78.09 (%)
7:28am
2018-11-06 $ 86.1 (2.74%)
11:02am
2018-11-02 $ 88.53 (-1.78%)
9:55am
2018-11-01 $ 90.13 (2.18%)
9:24pm
4:15pm
2018-10-04 $ 96.29 (-3.91%)
10:39am
2018-09-20 $ 102.6 (-0.6%)
6:56am
2018-09-19 $ 103.22 (-1.33%)
8:55am
2018-08-27 $ 97.65 (3.81%)
11:39am
2018-08-17 $ 88.3 (0.31%)
6:28am
2018-08-16 $ 88.03 (2.12%)
8:30am
2018-08-07 $ 86.09 (0.47%)
7:50am
2018-08-02 $ 87.54 (4.38%)
10:51pm
4:15pm
2018-07-30 $ 81.43 (-2.24%)
11:18am
2018-07-27 $ 83.3 (-2.85%)
2:33pm
11:25am
9:32am
2018-07-26 $ 85.74 (0.14%)
3:04pm
8:51am
8:14am
7:58am
7:38am
2018-07-25 $ 85.62 (2.18%)
11:10am
10:04am
9:18am
2018-07-24 $ 83.79 (-2.89%)
9:42am
7:31am
2018-07-18 $ 88.65 (1.48%)
11:43am
2018-07-05 $ 87.4 (1.26%)
9:42am
2018-07-03 $ 86.31 (0.36%)
10:06am
8:27am
2018-06-26 $ 92.8 (1.52%)
10:09am
2018-06-06 $ 96.57 (1.1%)
1:36am
2018-06-01 $ 94.82 (1.1%)
11:30am
2018-05-31 $ 93.79 (0.05%)
7:02am
2018-05-14 $ 87.22 (1.01%)
12:14pm
2018-05-04 $ 83.88 (-3.69%)
9:42am
2018-04-23 $ 86.45 (-0.28%)
7:19am
2018-03-19 $ 84.19 (-1.22%)
3:48pm
2018-03-12 $ 83.15 (3.51%)
12:54pm
2018-02-22 $ 80.46 (3.5%)
8:02am
2018-01-17 $ 72.91 (-1.19%)
12:10pm
2018-01-16 $ 73.79 (-2.42%)
11:25am
2018-01-08 $ 78.12 (13.61%)
2:48pm
2017-11-06 $ 69.86 (0.59%)
3:45pm
2017-11-03 $ 69.45 (19.43%)
12:22pm
10:02am
2017-10-30 $ 58.34 (1.36%)
9:33am
2017-09-27 $ 57.74 (2.01%)
10:19am
2017-09-21 $ 57.16 (-1.16%)
11:05am
12:45pm
- seekingalpha.com
Total 116
  • 1
  • 2